Effects of exergaming on cognition in individuals with schizophrenia
Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study
This study is testing if playing active video games can help improve thinking skills and reduce symptoms for people with schizophrenia.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Sykehuset i Vestfold HF Academic / other |
| Locations | 1 site (Tønsberg, Vestfold) |
| Trial ID | NCT05858255 on ClinicalTrials.gov |
What this trial studies
This clinical intervention focuses on the impact of exergaming on cognitive function and clinical symptoms in outpatient individuals diagnosed with schizophrenia. Participants will engage in two 45-minute exergaming sessions per week for 12 weeks, guided by a personal trainer. The study aims to determine if this innovative approach can enhance cognitive abilities, reduce symptoms, and improve overall quality of life. Results will be compared to previous research conducted at the same site to assess the effectiveness of this intervention.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with schizophrenia spectrum disorders who can understand and communicate in a Scandinavian language.
Not a fit: Patients with intellectual disabilities, neurological disorders, or other serious medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve cognitive function and quality of life for patients with schizophrenia.
How similar studies have performed: Previous studies on physical activity and cognitive function in schizophrenia have shown promising results, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Having consent capability * Understanding and speaking Scandinavian language * Fulfilling the International Classification of Diseases Tenth Revision (ICD 10) criteria for schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder and schizophreniform disorder) Exclusion Criteria: * Diagnosis of intellectual disability * Diagnosis of neurological disorder * History of severe head trauma * Pregnancy * Chest pain during exercise * Unstable angina pectoris * Malignant hypertension * Uncontrollable arrhythmia * Recent myocardial infarction * Acute infection with lymphadenopathy * Other specified medical condition incompatible with participation
Where this trial is running
Tønsberg, Vestfold
- DPS Vestfold, Vestfold Sykehus HF — Tønsberg, Vestfold, Norway (Recruiting)
Study contacts
- Principal investigator: Tom Langerud Holmen, PhD — Sykehuset i Vestfold HF
- Study coordinator: Tom Langerud Holmen, PhD
- Email: lantom@siv.no
- Phone: 97119323
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.